摘要
目的分析247例分化型甲状腺癌(differentiated thyroid carcinoma,DTC)合并结节性甲状腺肿(nodular Goiter,NG)患者经全切或次全切术后我科接受131 I治疗前血清抗甲状腺球蛋白抗体(antithyroglobulin antibody,TgAb)的水平对甲状腺癌复发或转移的诊断价值,并确定其相应的截断值。方法DTC合并NG患者根据TgAb水平分为TgAb阳性和阴性两组,并比较两组患者的临床病理特征。经随访所有患者分为有或无复发/转移两组,进行受试者特征工作曲线(receiver operating characteristic,ROC)分析,计算DTC合并NG患者消融前TgAb预测复发或转移的截断值。结果研究数据显示,TgAb阳性患者的TNM分期I级高于TgAb阴性组患者,且差异具有统计学意义。在DTC合并NG患者中,以ROC分析计算出TgAb预测复发或转移的截断值为152.3kIU/L(灵敏度65.4%,特异性78.4%)。TgAb的曲线下面积(AUC)为0.757。结论在DTC合并NG患者中,以ROC曲线得出的TgAb预测复发或转移的截断值为152.3kIU/L。
Objective To analyze the diagnostic value of preablation stimulated serum anti-thyroglobulin antibody(TgAb)levels for a total of 247 patients with differentiated thyroid carcinoma(DTC)complicated with nodular goiter(NG)underwent the I-131 treatment after the operation and to determine corresponding cutoff values.Methods The studied patients were divided into the TgAb-positive and TgAb-negative group.Demographic characteristics and long-term outcomes(follow-up range:9-30 months)were compared between groups.Receiver operating characteristic(ROC)curve analysis was conducted to analyze cutoff values of TgAb for predicting the metastasis for patients with DTC complicated with NG.Results TNM stage I of TgAb-positive patients was superior to the TgAb-negative group(P=0.027).In patients with DTC complicated with NG,the cut off values of TgAb for predicting the metastasis was 152.3kIU/L(with sensitivity of 65.4%and specificity of 78.4%)according to ROC analysis.AUCs of Tg and TgAb was 0.757.Conclusion For patients with DTC complicated with NG,the cutoff value of TgAb for predicting the metastasis is 152.3kIU/L according to ROC curves.
作者
祁爱花
柴红
QI Aihua;CHAI Hong(The Sixth People’s Hospital,Shanghai Jiaotong University,Shanghai 200233,China)
出处
《标记免疫分析与临床》
CAS
2022年第12期2030-2034,共5页
Labeled Immunoassays and Clinical Medicine
基金
上海市卫生和计划生育委员会科研课题(编号:20164Y0202)。